Bio Pharma Dive
MARCH 4, 2022
The Danish drugmaker aims to triple sales of its weight loss treatments Wegovy and Saxenda by 2025. But first Novo needs to resolve manufacturing constraints that have slowed the former drug's launch.
pharmaphorum
MARCH 4, 2022
With prospects of an early, accelerated approval for Roche’s Alzheimer’s disease candidate gantenerumab looking diminished, the drugmaker has launched a new four-year trial in the hope of building its case for the drug. The new placebo-controlled SKYLINE study will enrol 1,250 people aged 60 to 80 with the earliest biological signs of Alzheimer’s – in other words signs of amyloid accumulation in the central nervous system – but no cognitive impairment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
MARCH 4, 2022
Toronto-based Swift Medical, a leader in digital wound care technologies, has introduced a new imaging device that can assist in the treatment and monitoring of skin and wound conditions. The medical device, Swift Ray 1 , is the world’s first all-in-one hyperspectral imaging device. Small enough to fit into the palm of your hand and in your pocket, the digital wound care device is wirelessly mounted onto the camera of a smartphone, offering powerful collection of images of the skin.
pharmaphorum
MARCH 4, 2022
The pharmaceutical industry is still picking its way through the debris of the pandemic but the gloom can be illuminated by the power of coaching to drive connections and value. It is clear that sales forces and MSL teams need to enhance their skills to make every second of their precious time in front of HCPs count. They are facing unprecedented challenge as traditional routes evaporate which means they need to be pitch perfect when they have a window of attention either in person or across dig
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
MARCH 4, 2022
Ziscuit, an online grocery search engine, allows food insecure customers and those that reside in food deserts to find the best-priced food items located near them. The Atlanta-based startup aims to save customers hours of coupon clipping and driving aimlessly from store to store. At a time when inflation is on the rise, Ziscuit allows everyone to locate cheaper groceries with ease.
Scienmag
MARCH 4, 2022
Lyme disease is carried by black-legged ticks and infects people when they are bitten and transmit the bacterium Borrelia burgdorferi. Black-legged ticks are especially common in the northeastern United States, and people are exposed to the ticks usually during outdoor activities. Warming temperatures and climate change have caused tick populations to explode and infiltrate more areas […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MARCH 4, 2022
Sightings of more than 1 million marine mammals in the federally protected Northeast Canyons and Seamounts Marine National Monument and sites along the Atlantic Coast have been used to identify areas of high marine mammal diversity. These findings underscore the importance of ocean conservation as these waters face increasing impacts from human activities.
pharmaphorum
MARCH 4, 2022
Purdue Pharma and its controlling Sackler family have reach a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion. The new deal has been accepted by a group of states and districts who refused to accept the $4.5 settlement deal proffered last year by the family in return for immunity from current and future civil lawsuits accusing them of contributing to the opioid epidemic.
Pharma Times
MARCH 4, 2022
UKHSA reports an increase in norovirus cases throughout educational settings – particularly in nursery and childcare facilities
Scienmag
MARCH 4, 2022
Landon Marston, assistant professor in the Charles E. Via, Jr. Department of Civil and Environmental Engineering, has received a National Science Foundation Faculty Early Career Development (CAREER) award. His resulting project will use an integrated systems approach to uncover the drivers of industrial water use, water infrastructure dependencies within the U.S. economy, and water scarcity risks […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
MARCH 4, 2022
New detailed datasets will more accurately map out the impact of obesity throughout UK
Scienmag
MARCH 4, 2022
Tokyo, Japan – Researchers from Tokyo Metropolitan University have discovered key clues behind the workings of “single-atom” catalysts based on iron-pyridine sites in a carbon matrix. They firstly developed a new, simple synthesis method for a catalyst that activate peroxymonosulfate, highly effective in breaking down pollutants that do not easily biodegrade.
Drug Channels
MARCH 4, 2022
Today’s guest post comes from Miranda Gill, Vice President of Network at CoverMyMeds. Miranda discusses how integrated technology solutions can be used at critical moments in the patient’s journey to increase access, affordability, and adherence to therapies. To learn more about CoverMyMeds’ prescription decision support tools for the entire care team, visit CoverMyMeds at HIMSS22.
Scienmag
MARCH 4, 2022
DALLAS, March 4, 2022 — Poor heart health, especially among women of color, puts both mothers-to-be and their infants at risk, with heart disease causing more than one in four pregnancy-related deaths (26.5%) in the U.S., according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update. To address this growing concern, the American Heart […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
MARCH 4, 2022
Novo Nordisk’s rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates it will help drive obesity sales to 25 billion kroner ($3.69 billion) in 2025, twice its earlier forecast. Camilla Sylvest, Novo Nordisk’s head of commercial strategy and corporate affairs, said at the company’s Capital Markets Day yesterday that the company expects to meet demand for Wegovy in the US in the second half of
Scienmag
MARCH 4, 2022
LSU physicists have leveraged quantum information theory techniques to reveal a mechanism for amplifying, or “stimulating,” the production of entanglement in the Hawking effect in a controlled manner. Furthermore, these scientists propose a protocol for testing this idea in the laboratory using artificially produced event horizons. These results have been recently published in Physical Review […].
ECRG Media's Clinical Research Podcast
MARCH 4, 2022
Can I Get Into Clinical Research With No College Degree? Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group or ECRG for short is a
Scienmag
MARCH 4, 2022
It may seem counterintuitive to many, but metal ions play a critical role in life, carrying out some of the most important biological processes. Think of hemoglobin—a metalloprotein responsible for carrying oxygen to the body’s organs via red blood cells. Metalloproteins are proteins bound by at least one metal ion. In the case of hemoglobin, […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
ECRG Media's Clinical Research Podcast
MARCH 4, 2022
Can I Get Into Clinical Research With No College Degree? Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Scienmag
MARCH 4, 2022
An interdisciplinary research team at The University of Texas at San Antonio has successfully developed an innovative inhibitor that shows promise in fighting obesity and potentially preventing heart disease. Francis Yoshimoto, an assistant professor in the UTSA College of Sciences’ Department of Chemistry, is leading a team that developed an anti-obesity drug that blocks the effects […].
Drug Patent Watch
MARCH 4, 2022
Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are fifteen…. The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
MARCH 4, 2022
By combining CRISPR technology with a protein designed with artificial intelligence, it is possible to awaken individual dormant genes by disabling the chemical “off switches” that silence them. Researchers from the University of Washington School of Medicine in Seattle describe this finding in the journal Cell Reports. Credit: Thatcher Heldring/UW Medicine Institute for Stem Cell and Regenerative […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Intouch Solutions
MARCH 4, 2022
More than 7,000 rare diseases currently affect 25 to 30 million (or one in 10) Americans. Rare diseases are considered “rare” if they occur in fewer than 200,000 people, and how they manifest can vary widely. But what they often have in common is the obstacle course patients must navigate to get treatment, IF a treatment even exists … at this time, in fact, 95% of rare diseases have no treatment.
Scienmag
MARCH 4, 2022
Overview Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RESERVED. Overview Associate Professor Kazuhiro Takahashi and Tomoya Maeda (a second-year Master’s student) and other members of the Department of Electrical and Electronic Information Engineering at Toyohashi University of Technology have developed a semiconductor sensor capable of detecting ultra-low concentrations of tumor markers, on chips […].
pharmaphorum
MARCH 4, 2022
Eli Lilly and Incyte’s JAK inhibitor Olumiant reduced the risk of death by 13% in hospitalised COVID-19 patients when added to other drugs, according to new results from the UK RECOVERY trial. The benefit came when Olumiant (baricitinib) added to the steroid dexamethasone and Roche’s IL-6 inhibitor Actemra/RoActemra (tocilizumab), two other anti-inflammatory drugs that have also been shown to improve survival in severe COVID-19 cases, as well as Gilead’s antiviral Veklury (remd
Scienmag
MARCH 4, 2022
John Wikswo, founder and director of the Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, is the principal investigator of a $1 million award from the National Science Foundation. The object is to build a pathbreaking “robot scientist”—a fully automated microfluidic system for parallel, independent, long-duration, machine-guided experiments.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
NY Times
MARCH 4, 2022
The vaccine, made by Bharat Biotech, is widely used in India. It has not been tested in the U.S., which has not authorized it for any age groups.
Scienmag
MARCH 4, 2022
Credit: Image credit: ESA/Hubble & NASA, T. Boeker, B. Holwerda, Dark Energy Survey, Department of Energy, Fermilab/Dark Energy Camera (DECam), Cerro Tololo Inter-American Observatory/NOIRLab/National Science Foundation/Association of Universities for Research in Astronomy, Sloan Digital Sky Survey; Acknowledgment: R. Colombari.
FDA Law Blog
MARCH 4, 2022
By Sara W. Koblitz & Dara Katcher Levy & Jeffrey N. Wasserstein — With our second OPDP enforcement letter of 2022, FDA is making one thing clear: OPDP will find your promotional content—even when it may not look like promotional content. While it’s not mind-blowing that OPDP would find a series of videos while scrolling Instagram (particularly when it’s flagged by FDA’s Bad Ad program), OPDP issued a Warning Letter on February 11 concerning a little-seen interview with the former CEO of
Scienmag
MARCH 4, 2022
NEW YORK — Take a cell-deep tour of a brain afflicted with Alzheimer’s disease, and you will find minuscule clumps of protein that seem suspicious. Ever since the 1980s, when neuroscientists began identifying these protein tangles, researchers have discovered that other brain diseases have their own tangled-protein signatures. Credit: Andrew Chang and Anthony Fitzpatrick / […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
169 
Let's personalize your content